Your browser doesn't support javascript.
loading
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.
Qureshy, Zoya; Li, Hua; Zeng, Yan; Rivera, Jose; Cheng, Ning; Peterson, Christopher N; Kim, Mi-Ok; Ryan, William R; Ha, Patrick K; Bauman, Julie E; Wang, Steven J; Long, Steven R; Johnson, Daniel E; Grandis, Jennifer R.
Affiliation
  • Qureshy Z; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Li H; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Zeng Y; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Rivera J; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Cheng N; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Peterson CN; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Kim MO; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
  • Ryan WR; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Ha PK; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Bauman JE; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
  • Wang SJ; Division of Hematology and Oncology, University of Arizona College of Medicine, Tucson, Arizona.
  • Long SR; Department of Otolaryngology-Head and Neck Surgery, University of Arizona College of Medicine, Tucson, Arizona.
  • Johnson DE; Department of Pathology, University of California San Francisco, San Francisco, California.
  • Grandis JR; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California.
Clin Cancer Res ; 28(21): 4737-4746, 2022 11 01.
Article in En | MEDLINE | ID: mdl-35929989
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Head and Neck Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Head and Neck Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: